Comments
Loading...

Intensity Therapeutics

INTSNASDAQ
Logo brought to you by Benzinga Data
$4.61
0.4410.55%
Pre-Market: Aug 9, 8:59 AM EDT
15 minutes delayed
Consensus Rating1
Speculative Buy
Highest Price Target1
$12.00
Lowest Price Target1
$12.00
Consensus Price Target1
$12.00

Intensity Therapeutics (NASDAQ:INTS) Stock, Analyst Ratings, Price Targets, Forecasts

Intensity Therapeutics Inc has a consensus price target of $12 based on the ratings of 1 analysts. The high is $12 issued by Benchmark on July 11, 2024. The low is $12 issued by Benchmark on July 11, 2024. The 3 most-recent analyst ratings were released by Benchmark on July 11, 2024, May 16, 2024, and March 21, 2024, respectively. With an average price target of $12 between Benchmark, there's an implied 160.30% upside for Intensity Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
0
0
0
0
May
0
0
0
0
Jul
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Benchmark

1calculated from analyst ratings

Analyst Ratings for Intensity Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Intensity Therapeutics (INTS) stock?

A

The latest price target for Intensity Therapeutics (NASDAQ:INTS) was reported by Benchmark on July 11, 2024. The analyst firm set a price target for $12.00 expecting INTS to rise to within 12 months (a possible 160.30% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Intensity Therapeutics (INTS)?

A

The latest analyst rating for Intensity Therapeutics (NASDAQ:INTS) was provided by Benchmark, and Intensity Therapeutics reiterated their speculative buy rating.

Q

When was the last upgrade for Intensity Therapeutics (INTS)?

A

There is no last upgrade for Intensity Therapeutics

Q

When was the last downgrade for Intensity Therapeutics (INTS)?

A

There is no last downgrade for Intensity Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Intensity Therapeutics (INTS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Intensity Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Intensity Therapeutics was filed on July 11, 2024 so you should expect the next rating to be made available sometime around July 11, 2025.

Q

Is the Analyst Rating Intensity Therapeutics (INTS) correct?

A

While ratings are subjective and will change, the latest Intensity Therapeutics (INTS) rating was a reiterated with a price target of $12.00 to $12.00. The current price Intensity Therapeutics (INTS) is trading at is $4.61, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch